SCHEMBL15560941

SCHEMBL15560941

CN(C(Cc1ccc(C2CCCCC2)cc1)C(=O)Nc1ccc(C(=O)OCc2ccccc2)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 17/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15559939 0.89 STAT3 (0.47) STAT3
SCHEMBL15559484 0.88 STAT3 (0.53) STAT3
SCHEMBL15559430 0.88 STAT3 (0.53) STAT3
SCHEMBL12466793 0.84 STAT3 (0.51) STAT3
SCHEMBL20418445 0.79 STAT3 (0.69) STAT3
SCHEMBL28809685 0.78 STAT3 (0.42) STAT3
SCHEMBL28810587 0.76 PTPN1 (0.44) STAT3
SCHEMBL16767353 0.75 STAT3 (0.69) STAT3
SCHEMBL27941489 0.75 STAT3 (0.42) STAT3
SCHEMBL20418387 0.75 STAT3 (1.00) STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2854819-A2 NEW SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF The Governing Council of the University of Toronto (CA) 2015-04-08 EP disclosed
WO-2013177534-A2 NEW SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2013-11-28 WO disclosed